Expression and Predictive Value of Angiopoietin-2 in Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease
Clear and effective treatment for pulmonary hypertension (PH) caused by chronic obstructive pulmonary disease (COPD) has not been established, and thus promptly identifying patients with PH is of particular importance. In this study, by comparing Angiopoietin-2 expression in patients with COPD and C...
Saved in:
| Main Authors: | Ruiqin Ni, Mengrong Xie, Jingying Zhang, Mingmei Zhong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | COPD |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15412555.2025.2512749 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Angiopoietin-2 and D-dimer add prognostic information to clinical risk in pulmonary arterial hypertension
by: Heather L. Clark, et al.
Published: (2025-02-01) -
Clinical Case of Pulmonary Hypertension Secondary to Chronic Obstructive Pulmonary Disease in the Patient with History of Pulmonary Tuberculosis
by: M. V. Moiseeva, et al.
Published: (2023-12-01) -
ARTERIAL HYPERTENSION IN PATIENTS WITH BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: N. A. Karoli, et al.
Published: (2014-07-01) -
Pecularities of the clinical course of chronic obstructive pulmonary disease in hypertensive patients.
by: O. L. Arkhipkina
Published: (2019-06-01) -
A prevalence study focusing on hospitalized COPD related pulmonary hypertension
by: Ting-Chia Chang, et al.
Published: (2025-04-01)